Nifty
Sensex
:
:
17629.50
59141.16
110.05 (0.63%)
417.96 (0.71%)

Pharmaceuticals & Drugs - Global

Rating :
35/99

BSE: 506197 | NSE: BLISSGVS

112.10
16-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  111.85
  •  114.75
  •  111.30
  •  111.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  560100
  •  632.61
  •  221.00
  •  91.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,149.47
  • 15.02
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,123.67
  • 0.45%
  • 1.39

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.24%
  • 8.10%
  • 26.90%
  • FII
  • DII
  • Others
  • 21.24%
  • 6.72%
  • 3.80%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.01
  • -6.28
  • -13.72

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.10
  • -12.06
  • -7.52

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.69
  • -3.55
  • -17.89

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.36
  • 18.86
  • 15.67

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.80
  • 2.64
  • 2.07

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.90
  • 8.79
  • 8.94

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
168.15
129.55
29.80%
132.05
119.80
10.23%
164.06
147.85
10.96%
151.54
210.12
-27.88%
Expenses
133.54
110.07
21.32%
115.17
103.86
10.89%
125.78
114.90
9.47%
119.54
184.66
-35.26%
EBITDA
34.60
19.48
77.62%
16.88
15.94
5.90%
38.28
32.95
16.18%
32.00
25.47
25.64%
EBIDTM
20.58%
15.03%
12.79%
13.31%
23.33%
22.28%
21.12%
12.12%
Other Income
7.82
7.04
11.08%
6.33
18.66
-66.08%
4.12
5.52
-25.36%
2.74
12.90
-78.76%
Interest
1.40
1.83
-23.50%
2.36
4.55
-48.13%
0.94
1.08
-12.96%
0.38
1.05
-63.81%
Depreciation
4.33
4.29
0.93%
4.27
3.34
27.84%
4.36
2.97
46.80%
4.31
3.50
23.14%
PBT
36.69
20.40
79.85%
16.58
13.33
24.38%
37.09
34.41
7.79%
30.05
33.81
-11.12%
Tax
10.55
3.75
181.33%
8.43
7.76
8.63%
9.53
8.96
6.36%
8.44
2.95
186.10%
PAT
26.13
16.65
56.94%
8.15
5.57
46.32%
27.56
25.45
8.29%
21.61
30.86
-29.97%
PATM
15.54%
12.85%
6.17%
4.65%
16.80%
17.21%
14.26%
14.69%
EPS
2.35
1.57
49.68%
0.61
0.85
-28.24%
2.48
2.30
7.83%
1.99
3.00
-33.67%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
615.80
577.21
689.31
898.57
814.64
798.44
546.89
407.13
344.64
396.63
267.07
Net Sales Growth
1.40%
-16.26%
-23.29%
10.30%
2.03%
46.00%
34.33%
18.13%
-13.11%
48.51%
 
Cost Of Goods Sold
336.23
328.90
439.97
612.26
391.13
358.93
237.18
152.77
132.01
167.90
145.83
Gross Profit
279.57
248.30
249.34
286.31
423.52
439.51
309.72
254.37
212.63
228.72
121.24
GP Margin
45.40%
43.02%
36.17%
31.86%
51.99%
55.05%
56.63%
62.48%
61.70%
57.67%
45.40%
Total Expenditure
494.03
470.56
565.99
740.93
617.50
595.70
391.17
303.70
273.42
285.47
195.73
Power & Fuel Cost
-
8.14
5.88
4.76
5.49
5.58
4.72
4.36
2.93
2.18
1.02
% Of Sales
-
1.41%
0.85%
0.53%
0.67%
0.70%
0.86%
1.07%
0.85%
0.55%
0.38%
Employee Cost
-
68.09
53.69
42.32
69.23
61.35
33.74
29.43
23.46
15.08
6.26
% Of Sales
-
11.80%
7.79%
4.71%
8.50%
7.68%
6.17%
7.23%
6.81%
3.80%
2.34%
Manufacturing Exp.
-
7.83
7.07
4.95
4.88
5.39
25.65
29.98
41.44
37.17
12.66
% Of Sales
-
1.36%
1.03%
0.55%
0.60%
0.68%
4.69%
7.36%
12.02%
9.37%
4.74%
General & Admin Exp.
-
12.03
13.27
17.05
39.48
36.36
24.68
17.07
15.16
14.63
7.36
% Of Sales
-
2.08%
1.93%
1.90%
4.85%
4.55%
4.51%
4.19%
4.40%
3.69%
2.76%
Selling & Distn. Exp.
-
31.35
28.83
34.72
62.09
92.46
42.51
47.05
35.12
40.26
21.13
% Of Sales
-
5.43%
4.18%
3.86%
7.62%
11.58%
7.77%
11.56%
10.19%
10.15%
7.91%
Miscellaneous Exp.
-
14.21
17.28
24.86
45.21
35.63
22.71
23.03
23.30
8.25
21.13
% Of Sales
-
2.46%
2.51%
2.77%
5.55%
4.46%
4.15%
5.66%
6.76%
2.08%
0.55%
EBITDA
121.76
106.65
123.32
157.64
197.14
202.74
155.72
103.43
71.22
111.16
71.34
EBITDA Margin
19.77%
18.48%
17.89%
17.54%
24.20%
25.39%
28.47%
25.40%
20.67%
28.03%
26.71%
Other Income
21.01
20.22
39.19
37.63
26.54
12.51
24.35
20.29
28.00
14.07
15.75
Interest
5.08
5.51
7.57
4.41
22.80
19.69
18.61
16.41
17.98
9.72
4.03
Depreciation
17.27
17.23
12.59
8.94
21.38
20.14
13.26
11.30
10.68
6.03
3.65
PBT
120.41
104.13
142.35
181.92
179.49
175.40
148.19
96.02
70.56
109.48
79.42
Tax
36.95
30.16
33.71
55.25
56.63
62.72
48.05
34.63
29.53
49.90
26.88
Tax Rate
30.69%
28.96%
26.14%
30.37%
38.98%
35.76%
32.42%
36.07%
41.85%
45.58%
33.85%
PAT
83.45
68.49
97.26
123.72
58.78
82.04
82.49
59.91
40.99
57.72
52.54
PAT before Minority Interest
76.55
73.97
95.25
126.66
88.66
112.68
100.15
61.39
41.03
59.58
52.54
Minority Interest
-6.90
-5.48
2.01
-2.94
-29.88
-30.64
-17.66
-1.48
-0.04
-1.86
0.00
PAT Margin
13.55%
11.87%
14.11%
13.77%
7.22%
10.28%
15.08%
14.72%
11.89%
14.55%
19.67%
PAT Growth
6.27%
-29.58%
-21.39%
110.48%
-28.35%
-0.55%
37.69%
46.16%
-28.98%
9.86%
 
EPS
8.07
6.62
9.41
11.97
5.68
7.93
7.98
5.79
3.96
5.58
5.08

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
808.25
735.61
646.00
536.24
486.62
412.62
337.08
286.88
258.01
210.66
Share Capital
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
Total Reserves
788.10
725.30
635.68
525.92
476.31
402.31
326.77
276.57
247.69
200.35
Non-Current Liabilities
45.24
46.32
37.99
12.92
32.81
49.55
67.52
95.65
96.92
39.34
Secured Loans
32.60
37.24
32.54
5.92
25.58
29.62
55.03
78.80
89.97
37.63
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
8.62
2.23
8.79
1.33
0.00
Long Term Provisions
2.50
2.44
1.75
1.91
2.05
1.81
1.40
1.10
0.74
0.51
Current Liabilities
203.64
230.53
207.03
299.40
437.09
378.97
242.68
307.66
202.19
59.74
Trade Payables
74.22
89.92
78.88
58.43
98.25
108.49
80.33
82.35
118.15
40.15
Other Current Liabilities
53.69
57.21
50.24
124.46
99.93
52.76
70.30
42.12
24.45
6.10
Short Term Borrowings
65.04
66.39
64.30
105.66
187.47
62.12
61.04
57.05
45.16
5.90
Short Term Provisions
10.69
17.01
13.61
10.85
51.45
155.60
31.00
126.14
14.44
7.58
Total Liabilities
1,076.79
1,027.22
904.88
860.04
1,022.90
874.24
662.17
700.35
570.92
309.74
Net Block
233.72
240.97
144.97
136.48
303.86
225.25
234.38
213.31
168.23
40.03
Gross Block
285.10
276.07
169.89
157.47
326.83
300.74
293.82
262.45
205.92
64.41
Accumulated Depreciation
51.38
35.10
24.92
20.99
22.97
75.48
59.44
49.14
37.69
24.38
Non Current Assets
311.59
257.48
211.39
170.25
456.97
291.23
244.66
229.67
219.61
100.21
Capital Work in Progress
2.39
0.00
46.74
0.47
4.03
9.10
0.00
4.33
0.65
6.91
Non Current Investment
0.70
0.72
0.72
6.30
1.05
0.11
0.01
0.01
0.01
0.00
Long Term Loans & Adv.
12.63
14.56
18.63
26.72
11.45
56.77
10.27
12.02
50.72
53.28
Other Non Current Assets
62.15
1.24
0.33
0.29
136.58
0.00
0.00
0.00
0.00
0.00
Current Assets
765.20
769.74
693.49
689.79
565.93
583.00
417.08
469.26
348.89
209.54
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.80
Inventories
98.93
74.14
77.37
59.03
49.30
38.67
33.70
32.53
32.52
12.68
Sundry Debtors
463.82
547.91
460.73
298.48
254.45
300.93
247.47
215.03
244.64
128.59
Cash & Bank
144.55
103.32
106.63
88.86
150.50
78.18
57.29
80.37
50.35
58.01
Other Current Assets
57.90
16.13
26.21
97.11
111.68
165.22
78.62
141.34
21.37
9.46
Short Term Loans & Adv.
35.78
28.24
22.55
146.30
78.44
149.92
60.69
130.30
8.92
5.09
Net Current Assets
561.56
539.21
486.47
390.39
128.84
204.03
174.40
161.60
146.70
149.80
Total Assets
1,076.79
1,027.22
904.88
860.04
1,022.90
874.23
662.17
700.35
570.91
309.75

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
63.97
46.70
39.95
17.64
289.47
112.95
48.94
41.15
6.50
35.46
PBT
104.13
128.97
181.91
179.49
175.40
148.19
96.02
70.56
109.48
79.42
Adjustment
46.29
26.85
-10.97
17.55
36.24
18.18
22.48
24.11
9.71
4.76
Changes in Working Capital
-57.89
-70.32
-183.07
-140.80
113.48
-8.33
-60.94
-19.30
-73.94
-37.83
Cash after chg. in Working capital
92.53
85.49
-12.13
56.24
325.13
158.05
57.56
75.36
45.25
46.35
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-28.56
-38.79
52.08
-38.61
-35.66
-45.10
-8.63
-34.21
-38.75
-10.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-46.99
-47.89
-73.52
50.24
-231.25
-49.84
-38.98
-10.90
-124.05
-21.91
Net Fixed Assets
-10.99
-65.98
-52.48
-1.04
42.08
-5.32
-28.78
-12.86
-12.91
-16.65
Net Investments
0.01
0.01
0.16
2.37
-0.95
-1.36
0.00
-0.01
-18.19
-1.03
Others
-36.01
18.08
-21.20
48.91
-272.38
-43.16
-10.20
1.97
-92.95
-4.23
Cash from Financing Activity
-20.80
-6.30
16.83
-75.98
-10.13
-40.25
-43.26
-8.47
109.89
26.48
Net Cash Inflow / Outflow
-3.82
-7.50
-16.74
-8.10
48.09
22.85
-33.31
21.77
-7.66
40.02
Opening Cash & Equivalents
15.34
15.04
36.95
47.41
0.00
5.09
49.57
27.79
58.01
17.98
Closing Cash & Equivalent
13.13
15.34
15.04
36.95
47.41
27.60
16.26
49.57
50.35
58.01

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
77.41
71.32
62.63
51.99
47.18
40.00
32.64
27.67
24.78
20.42
ROA
7.03%
9.86%
14.35%
9.42%
11.88%
13.04%
9.01%
6.46%
13.53%
20.09%
ROE
9.64%
13.79%
21.43%
17.34%
25.06%
26.73%
19.74%
15.17%
25.56%
27.85%
ROCE
12.29%
17.02%
26.58%
24.61%
31.06%
32.07%
23.57%
20.56%
36.18%
38.76%
Fixed Asset Turnover
2.06
3.09
5.49
3.37
2.56
1.85
1.47
1.48
2.95
5.09
Receivable days
319.89
267.05
154.20
123.80
126.33
182.13
206.07
241.81
171.03
169.17
Inventory Days
54.72
40.11
27.70
24.25
20.01
24.04
29.51
34.22
20.71
16.56
Payable days
62.91
56.62
35.01
51.74
67.63
95.25
108.77
148.76
105.12
67.61
Cash Conversion Cycle
311.70
250.53
146.89
96.31
78.70
110.92
126.81
127.26
86.63
118.11
Total Debt/Equity
0.15
0.16
0.16
0.22
0.46
0.32
0.47
0.60
0.58
0.21
Interest Cover
19.89
18.04
42.21
7.37
9.91
8.96
6.85
4.92
12.27
20.70

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.